2',3-dimethyl-4-aminobiphenyl has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asamoto, M; Cho, YM; Hokaiwado, N; Inaguma, S; Shirai, T; Suzuki, S; Takahashi, S | 1 |
Akaza, H; Ideyama, Y; Onozawa, M; Shirai, T; Tsukamoto, S | 1 |
2 other study(ies) available for 2',3-dimethyl-4-aminobiphenyl and Disease Exacerbation
Article | Year |
---|---|
Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.
Topics: Adenocarcinoma; Age Factors; Aminobiphenyl Compounds; Androgen Antagonists; Androgen-Binding Protein; Animals; Animals, Genetically Modified; Antigens, Polyomavirus Transforming; Carcinogens; Disease Progression; Drug Implants; Ethinyl Estradiol; Heterozygote; Imidazoles; Ki-67 Antigen; Male; Mammary Neoplasms, Experimental; Neoplasm Proteins; Orchiectomy; Phenotype; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Testosterone; Tongue Neoplasms | 2003 |
A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adenocarcinoma; Aminobiphenyl Compounds; Androgen Antagonists; Anilides; Animals; Carcinogens; Disease Progression; Enzyme Inhibitors; Finasteride; Male; Nitriles; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Tosyl Compounds | 1998 |